Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis - PubMed (original) (raw)
. 2012 Jun 8;336(6086):1314-7.
doi: 10.1126/science.1221789. Epub 2012 Jun 6.
Vincent A Funari, Kent D Taylor, Quoclinh Nguyen, Christopher N Reyes, Samuel P Strom, Jordan Brown, Courtney A Becker, Phillip R Fleshner, Marla Dubinsky, Jerome I Rotter, Hanlin L Wang, Dermot P B McGovern, Gordon D Brown, David M Underhill
Affiliations
- PMID: 22674328
- PMCID: PMC3432565
- DOI: 10.1126/science.1221789
Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis
Iliyan D Iliev et al. Science. 2012.
Abstract
The intestinal microflora, typically equated with bacteria, influences diseases such as obesity and inflammatory bowel disease. Here, we show that the mammalian gut contains a rich fungal community that interacts with the immune system through the innate immune receptor Dectin-1. Mice lacking Dectin-1 exhibited increased susceptibility to chemically induced colitis, which was the result of altered responses to indigenous fungi. In humans, we identified a polymorphism in the gene for Dectin-1 (CLEC7A) that is strongly linked to a severe form of ulcerative colitis. Together, our findings reveal a eukaryotic fungal community in the gut (the "mycobiome") that coexists with bacteria and substantially expands the repertoire of organisms interacting with the intestinal immune system to influence health and disease.
Figures
Figure 1. Commensal fungi are present in the intestine and are recognized by Dectin-1
(A) Prevalence of fungi in mucosa isolated from ileum, caecum, proximal (prox) and distal (dist) colon of C57BL/6J mice. ITS1-2 rDNA level was analyzed by qPCR and normalized to β-actin DNA. (B) Visualization of commensal fungi in the intestine. Colon sections were stained with a soluble Dectin-1 probe (sDEC-1) and counterstained with DAPI. The DAPI signal has been amplified in lower panels (B) to show that DAPI-stained bacteria and fungi are in close proximity to each other. (C) Intestinal fungi are recognized by Dectin-1. Fecal pellets were homogenized and labeled with sDEC-1 in presence (gray histogram) or absence (black histogram) of laminarin (a soluble β-glucan) to block specific binding. Binding was assessed by flow cytometry (left panels). Dectin-1-binding fungi were sorted (right panels) and visualized by confocal microscopy. (D) ASCA generation after DSS colitis. Mice were exposed twice to 2.5% DSS-supplemented water for 7 days each separated by two weeks of recovery. Serum samples were collected before DSS treatment (day 0) and 2 weeks after the last DSS cycle (42 days total) and ASCA IgM and IgG were measured by ELISA. Each symbol represents a mouse, all error bars indicate the s.d. *P < 0.05; unpaired t test. All data are representative of at least two independent experiments with similar results.
Figure 2. Dectin-1 regulates severity of colitis
Wild type (WT) and _Clec7a_−/− littermates were treated with 2.5% DSS for 7 days and kept on water for 4 additional days. Colitis progress and severity were assessed by measuring body weight during treatment (A) and histology (B, C), and TNF-α production in the colon (D) on day 11. (E, F) WT and _Clec7a_−/− mice were given an antibiotic cocktail including fluconazole for 3 weeks, transplanted as indicated (red) with fecal microflora from WT or _Clec7a_−/− mice and treated with DSS as in (A). Disease severity was accessed by histology score (E) and by cytokine production by anti-CD3/anti-CD28 stimulated LI-LP and MLN T cells (F). Each symbol represents a different mouse. One of four independent experiments is shown. Error bars, s.d., * P < 0.05, ** P < 0.01.
Figure 3. Defining the fungal microbiome and characterizing the specific role of Dectin-1-mediated host defense during colitis
(A) DNA was isolated from murine feces and mycobiome analysis was performed using Roche 454 and Illumina GA sequencing of ITS1-2 rDNA. The taxonomic distribution of the most abundant fungal genera is shown (large pie chart), and species breakdown for major groups are provided (small pie charts). (B) Quantitative analysis of the major intestinal fungal genera in wild type and _Clec7a_−/− mice before and after treatment with DSS. Illumina GA data were analyzed and presented as relative percentage of dominant fungal genera (n=16 mice). (C) Fungal invasion of colonic tissue in _Clec7a_−/− mice during colitis. Colon sections from WT and _Clec7a_−/− mice before and after colitis were stained with the sDEC-1 probe and counterstained with DAPI. (D) Intestinally conditioned dendritic cells were incubated with live C. tropicalis and killing was assessed after 6 and 18 hours. (E) Histology score of WT and _Clec7a_−/− mice supplemented or not with four doses of C. tropicalis or S. fibuligera every other day, and then treated with 2.5% DSS for 7 days and kept on water for 4 additional days. Data are representative of at least two independent experiments with similar results. Error bars, s.d., * P < 0.05, ** P < 0.01.
Figure 4. Anti-fungal therapy ameliorates colitis in Clec7a−/− mice and CLEC7A associates with ulcerative colitis severity in humans
(A) WT and _Clec7a_−/− mice were given fluconazole in their drinking water for total of 14 days (starting 2 days prior the induction of DSS colitis), and body weight was measured. Weight loss is shown in (A) (p<0.05). Histology score (B), the percentage of IL-17 and IFN-γ producing CD4+ T cells in LI-LP (C), and IL-17 and IFN-γ production in MLNs (D) were determined 4 days after the 7 days of DSS treatment. Each symbol represents a different mouse. One of three independent experiments with similar results is shown. Error bars, s.d., * P < 0.05, ** P < 0.01. (E) Specific CLEC7A haplotypes associate with medically refractory ulcerative colitis (MRUC). Haplotypes were formed from rs2078178 and rs16910631 using PHASE v2.3. Haplotypes listed as “Other Combinations” were those that could not be reliably determined (posterior p<0.95). (F) The CLEC7A “AG/AG” haplotype associates with severity of disease as indicated by earlier progression to colectomy. Haplotypes were tested for association with time to surgery by fitting the MRUC/non-MRUC and time to surgery with a Cox proportional hazards model.
Comment in
- The mycobiome: influencing IBD severity.
Moyes DL, Naglik JR. Moyes DL, et al. Cell Host Microbe. 2012 Jun 14;11(6):551-2. doi: 10.1016/j.chom.2012.05.009. Cell Host Microbe. 2012. PMID: 22704612 Review. - Mucosal immunology: Don't forget our fungal friends.
Minton K. Minton K. Nat Rev Immunol. 2012 Jun 22;12(7):476. doi: 10.1038/nri3252. Nat Rev Immunol. 2012. PMID: 22728523 No abstract available.
Similar articles
- The mycobiome: influencing IBD severity.
Moyes DL, Naglik JR. Moyes DL, et al. Cell Host Microbe. 2012 Jun 14;11(6):551-2. doi: 10.1016/j.chom.2012.05.009. Cell Host Microbe. 2012. PMID: 22704612 Review. - Dectin-3 Deficiency Promotes Colitis Development due to Impaired Antifungal Innate Immune Responses in the Gut.
Wang T, Pan D, Zhou Z, You Y, Jiang C, Zhao X, Lin X. Wang T, et al. PLoS Pathog. 2016 Jun 9;12(6):e1005662. doi: 10.1371/journal.ppat.1005662. eCollection 2016 Jun. PLoS Pathog. 2016. PMID: 27280399 Free PMC article. - Deletion of both Dectin-1 and Dectin-2 affects the bacterial but not fungal gut microbiota and susceptibility to colitis in mice.
Wang Y, Spatz M, Da Costa G, Michaudel C, Lapiere A, Danne C, Agus A, Michel ML, Netea MG, Langella P, Sokol H, Richard ML. Wang Y, et al. Microbiome. 2022 Jun 14;10(1):91. doi: 10.1186/s40168-022-01273-4. Microbiome. 2022. PMID: 35698210 Free PMC article. - Cellular and molecular immunopathogenesis of ulcerative colitis.
Zhang SZ, Zhao XH, Zhang DC. Zhang SZ, et al. Cell Mol Immunol. 2006 Feb;3(1):35-40. Cell Mol Immunol. 2006. PMID: 16549047 Retracted. Review. - Fungi in Gastrointestinal Tracts of Human and Mice: from Community to Functions.
Li J, Chen D, Yu B, He J, Zheng P, Mao X, Yu J, Luo J, Tian G, Huang Z, Luo Y. Li J, et al. Microb Ecol. 2018 May;75(4):821-829. doi: 10.1007/s00248-017-1105-9. Epub 2017 Nov 6. Microb Ecol. 2018. PMID: 29110065 Review.
Cited by
- Unveiling the overlooked fungi: the vital of gut fungi in inflammatory bowel disease and colorectal cancer.
Huang Y, Wang Y, Huang X, Yu X. Huang Y, et al. Gut Pathog. 2024 Oct 15;16(1):59. doi: 10.1186/s13099-024-00651-7. Gut Pathog. 2024. PMID: 39407244 Free PMC article. Review. - From sugar binders to diabetes fighters: the lectin saga of antihyperglycemic activity through systematic review and meta-analysis.
Simha N A, Patil SM, M K J, N C, Wong LS, Kijsomporn J, Raj R, Ramu R. Simha N A, et al. Front Pharmacol. 2024 Sep 11;15:1382876. doi: 10.3389/fphar.2024.1382876. eCollection 2024. Front Pharmacol. 2024. PMID: 39323638 Free PMC article. - Oral administration of garlic-derived nanoparticles improves cancer immunotherapy by inducing intestinal IFNγ-producing γδ T cells.
Xu J, Yu Y, Zhang Y, Dai H, Yang Q, Wang B, Ma Q, Chen Y, Xu F, Shi X, Liu Z, Wang C. Xu J, et al. Nat Nanotechnol. 2024 Oct;19(10):1569-1578. doi: 10.1038/s41565-024-01722-1. Epub 2024 Jul 25. Nat Nanotechnol. 2024. PMID: 39054386 - The Role of Dietary Habits in the Pathogenesis and Development of Inflammatory Bowel Disease: A Narrative Review.
Ahadi M, Rouhbakhsh Zahmatkesh MR, Ebrahimi P, AkbariRad M. Ahadi M, et al. Middle East J Dig Dis. 2024 Jan;16(1):5-11. doi: 10.34172/mejdd.2024.362. Epub 2024 Jan 31. Middle East J Dig Dis. 2024. PMID: 39050099 Free PMC article. Review. - CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy.
Taheri MM, Javan F, Poudineh M, Athari SS. Taheri MM, et al. Clin Rev Allergy Immunol. 2024 Jun;66(3):328-362. doi: 10.1007/s12016-024-08998-0. Epub 2024 Jul 12. Clin Rev Allergy Immunol. 2024. PMID: 38995478 Review.
References
- Lupp C, et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe. 2007;2:204. - PubMed
- Willing BP, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139:1844. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UL1 RR033176/RR/NCRR NIH HHS/United States
- 086558/WT_/Wellcome Trust/United Kingdom
- UL1RR033176/RR/NCRR NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- R01 AI071116/AI/NIAID NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- P01 DK046763/DK/NIDDK NIH HHS/United States
- R01 DK093426/DK/NIDDK NIH HHS/United States
- AI071116/AI/NIAID NIH HHS/United States
- P01-DK046763/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases